Eli Lilly’s Mounjaro Arrives in India, Offering New Hope in the Fight Against Obesity and Diabetes
In a significant move aimed at addressing the growing health crisis of obesity and type 2 diabetes, pharmaceutical giant Eli Lilly has launched its highly anticipated drug, Mounjaro (tirzepatide), in India. This development brings a new and potentially powerful tool to the country’s healthcare arsenal, as India grapples with a rising prevalence of metabolic disorders. … Read more